2022
Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics
Forray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K, Hong S, Lipkind H, Fiellin DA, Callaghan K, Yonkers KA. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics. PLOS ONE 2022, 17: e0261751. PMID: 35025898, PMCID: PMC8758001, DOI: 10.1371/journal.pone.0261751.Peer-Reviewed Original ResearchConceptsOpioid use disorderPregnant womenUse disordersPrenatal clinicsClinical trialsReproductive health cliniciansCollaborative care approachTRIAL REGISTRATION NUMBERCommunity Healthcare OutcomesMatched-pair clusterPatient treatment engagementTreatment modelObstetric providersOUD treatmentPrimary outcomeObstetrical providersPostpartum womenHealth cliniciansCare approachRegistration numberTreatment engagementRelated treatmentsHealthcare outcomesTrialsWomen
2019
Accuracy of five self‐report screening instruments for substance use in pregnancy
Ondersma SJ, Chang G, Blake‐Lamb T, Gilstad‐Hayden K, Orav J, Beatty JR, Goyert GL, Yonkers KA. Accuracy of five self‐report screening instruments for substance use in pregnancy. Addiction 2019, 114: 1683-1693. PMID: 31216102, PMCID: PMC8407406, DOI: 10.1111/add.14651.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol DrinkingBlack or African AmericanCigarette SmokingFemaleHispanic or LatinoHumansMarijuana UseMass ScreeningOpioid-Related DisordersPregnancyPregnancy ComplicationsSelf ReportSensitivity and SpecificitySubstance Abuse DetectionSubstance-Related DisordersUnited StatesWhite PeopleYoung Adult
2017
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome
Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, Naimon R, Iskander J. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity And Mortality Weekly Report 2017, 66: 242-245. PMID: 28278146, PMCID: PMC5687191, DOI: 10.15585/mmwr.mm6609a2.Peer-Reviewed Original ResearchConceptsNeonatal abstinence syndromeMedication-assisted treatmentPrescription opioidsAbstinence syndromeCentral nervous system irritabilityDrug withdrawal syndromeOpioid use disorderHours of birthPublic health strategiesGastrointestinal dysfunctionOpioid exposurePain reliefWithdrawal syndromeUtero exposureClinical signsHealth strategiesUse disordersSyndromeOpioidsIllicit useExposurePregnancyDysfunctionInfantsIrritability
2014
Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy
Smith MV, Costello D, Yonkers KA. Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy. Maternal And Child Health Journal 2014, 19: 548-556. PMID: 24951127, PMCID: PMC4272915, DOI: 10.1007/s10995-014-1536-6.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidAnxiety DisordersComorbidityDepressive Disorder, MajorDrug PrescriptionsFemaleHumansIllicit DrugsOpioid-Related DisordersPainPregnancyPrevalenceProspective StudiesRegression AnalysisRisk FactorsStress Disorders, Post-TraumaticSurveys and QuestionnairesUnited StatesYoung AdultConceptsNon-opioid usersPregnant womenOpioid analgesicsClinical correlatesPrescription opioid analgesic useComposite International Diagnostic InterviewAnxiety disordersOpioid analgesic useProspective cohort studyUse of opioidsMajor depressive disorderPercent of womenPost-traumatic stress disorderAnalgesic useCohort studyOpioid useMedication useThird trimesterPsychiatric comorbidityDepressive disorderSmoking cigarettesOpioid addictionAmerican CollegeDiagnostic criteriaPregnancy